title: Treatment intensification in type 2 diabetes mellitus and obesity.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Zawiejska
authors.forename: Jane
authors.initials: J
authors.lastname: McAleese
authors.forename: Prasad
authors.initials: P
authors.lastname: Yemparala
authors.forename: Shahrad
authors.initials: S
authors.lastname: Taheri
mesh_terms: D000368:Aged; D015992:Body Mass Index; D050171:Dyslipidemias / Q000188:drug therapy*; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000819:agonists*; D006442:Glycated Hemoglobin / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D008875:Middle Aged; D009767:Obesity, Morbid / Q000150:complications / Q000188:drug therapy*; D020181:Sleep Apnea, Obstructive / Q000209:etiology; D016896:Treatment Outcome; D015431:Weight Loss / Q000187:drug effects*
chemical_list: D052216:Glucagon-Like Peptide 1; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; C517652:hemoglobin A1c protein, human
references.citation: Br J Gen Pract. 2013 Feb;63(607):60-1
references.pmid: 23561656